References
Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354–356.
Oshima Y, Sakaguchi H, Gomi F, et al. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:155–158.
Johnson M, Gong H, Freddo TF, et al. Serum protein and aqueous outflow resistance in bovine eyes. Invest Ophthalmol Vis Sci 1993;34;3549–3557.
Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005;167:1451–1459.
Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695–1705.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kubota, T., Aoki, R., Harada, Y. et al. Intravitreal injection of bevacizumab to treat neovascular glaucoma. Jpn J Ophthalmol 52, 410–412 (2008). https://doi.org/10.1007/s10384-008-0573-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0573-3